If your dog suffers from allergic itch, you have likely heard of Apoquel, Cytopoint, or the newer option Zenrelia. These three treatments represent the modern frontline of canine allergy management, and “Apoquel vs Cytopoint” is one of the most searched veterinary topics online. Each works through a different mechanism, comes in a different format, and carries its own set of benefits and limitations. None of them is universally “better” than the others; your veterinarian will choose based on your dog’s specific situation, including age, health history, severity of symptoms, and how your dog responds to treatment.
This guide provides a detailed, balanced comparison to help you have an informed conversation with your vet.
Understanding Canine Allergic Itch
Before comparing treatments, it helps to understand what is happening in your dog’s body. Canine atopic dermatitis (allergic skin disease) involves an overactive immune response to environmental triggers like pollen, dust mites, and mold. This immune response triggers a cascade of inflammatory signalling molecules, including cytokines like interleukins, that cause intense itching, redness, and skin inflammation.
Left untreated, allergic itch leads to:
- Constant scratching, licking, and chewing
- Hair loss and skin damage
- Secondary bacterial and yeast infections
- Thickened, darkened skin over time
- Significant reduction in quality of life
The goal of treatment is to interrupt the itch-inflammation cycle while addressing any underlying triggers and secondary infections.
The Three Treatments at a Glance
| Feature | Apoquel (oclacitinib) | Cytopoint (lokivetmab) | Zenrelia (ilunocitinib) |
|---|---|---|---|
| Manufacturer | Zoetis | Zoetis | Elanco |
| Drug class | JAK inhibitor | Monoclonal antibody (anti-IL-31) | JAK1-selective inhibitor |
| How given | Oral tablet | Subcutaneous injection at vet | Oral tablet |
| Frequency | Twice daily for 14 days, then once daily | Every 4 to 8 weeks | Once daily from day 1 |
| FDA approved | 2014 | 2016 | September 2024 |
| Age requirement | Dogs 12 months and older | No minimum age restriction on label | Dogs 12 months and older |
| Targets | JAK1 and JAK3 enzymes | IL-31 cytokine specifically | JAK1 enzyme (more selective) |
| Onset of itch relief | Many dogs within 1 to 2 days | Within 1 to 3 days for most dogs | Many dogs within 1 to 2 days |
| Monthly cost (est.) | $50 to $150 | $70 to $150 + possible office visit | Lower than Apoquel at label dose |
| Generic available | No | No | No |
Apoquel (Oclacitinib): Detailed Profile
How It Works
Apoquel inhibits Janus kinase (JAK) enzymes, specifically JAK1 and JAK3, which are key players in the signalling pathways that drive itch and inflammation. By blocking these enzymes, Apoquel interrupts the cascade that makes your dog scratch.
Administration
Apoquel is given as an oral tablet. The standard protocol is twice daily for the first 14 days, then once daily for maintenance. Tablets are available in 3.6 mg, 5.4 mg, and 16 mg strengths, and are dosed based on your dog’s weight.
Speed of Relief
Many dogs experience itch relief within 1 to 2 days of starting Apoquel, though response varies and veterinary oversight is essential. Some dogs show significant improvement within hours; others may take longer. Approximately 60 to 65% of dogs show meaningful improvement on Apoquel.
Side Effects
- Common: vomiting, diarrhea, decreased appetite (usually mild and transient)
- Potential concern: Apoquel suppresses certain immune pathways, which may increase susceptibility to infections (including demodicosis and skin infections) and, with long-term use, has theoretical concerns regarding tumour surveillance. Regular veterinary monitoring is recommended.
- Rebound itch: some dogs experience a return of itching when the dose transitions from twice daily to once daily
Who May Be a Candidate
- Dogs 12 months and older
- Dogs that need daily flexible dosing (easy to adjust, start, or stop)
- Dogs where owners prefer oral medication over injections
- Dogs with both itch and inflammation components
Who May Not Be a Candidate
- Dogs under 12 months of age
- Dogs with serious pre-existing infections
- Dogs with a history of cancer (discuss risk-benefit carefully with your vet)
- Dogs that are difficult to pill daily
Cytopoint (Lokivetmab): Detailed Profile
How It Works
Cytopoint is a monoclonal antibody: a laboratory-engineered protein designed to target and neutralise a specific cytokine called interleukin-31 (IL-31). IL-31 is a key driver of the itch sensation in allergic dogs. By binding to and neutralising IL-31, Cytopoint stops the itch signal before it reaches the brain.
Because Cytopoint is a biologic rather than a chemical drug, it is broken down by the body like any other protein. It does not go through the liver or kidneys for processing, which is one reason it is considered to have a different safety profile from small-molecule drugs like Apoquel.
Administration
Cytopoint is given as a subcutaneous injection at your veterinary clinic. Each injection typically provides relief for 4 to 8 weeks, though duration varies between individual dogs. Some dogs may need injections as frequently as every 4 weeks, while others maintain relief for 6 to 8 weeks.
Speed of Relief
Most dogs show reduced itching within 1 to 3 days of the injection. Peak effect is typically reached within 1 to 2 weeks.
Side Effects
- Common: injection site reactions (mild, uncommon)
- Reported adverse events: vomiting, diarrhea, lethargy (uncommon). Rare reports of hypersensitivity reactions and, in post-market surveillance, neurological signs have been reported.
- Key difference: because Cytopoint targets only IL-31 and does not suppress broader immune pathways in the same way as JAK inhibitors, it does not carry the same immunosuppression concerns associated with Apoquel or Zenrelia
Age and Cytopoint
Cytopoint has no minimum age restriction on its label, though safety data for pregnant, lactating, or breeding dogs is limited. Like any biologic, it should be given under veterinary supervision, and your veterinarian will consider your dog’s full health profile before recommending Cytopoint.
Who May Be a Candidate
- Dogs of various ages (no minimum age restriction on the label; vet supervision required)
- Dogs that are difficult to pill or where owners prefer not to give daily medication
- Dogs with liver or kidney concerns (Cytopoint is metabolised as a protein, not through liver/kidneys)
- Dogs where immunosuppression from JAK inhibitors is a concern
Who May Not Be a Candidate
- Dogs with known hypersensitivity to the product
- Dogs where owners cannot make regular vet visits for injections
- Dogs whose itch has a significant inflammation component beyond what IL-31 blockade addresses (some dogs may need additional anti-inflammatory therapy)
Zenrelia (Ilunocitinib): Detailed Profile
How It Works
Zenrelia is a next-generation JAK inhibitor that is more selective for JAK1 than Apoquel. By focusing more narrowly on JAK1, Zenrelia aims to control allergic itch and inflammation while potentially affecting fewer off-target immune pathways. However, it remains an immunomodulatory drug and carries its own set of safety considerations.
Administration
Zenrelia is given as a once-daily oral tablet from day one, unlike Apoquel, which requires a twice-daily loading period. This simpler dosing schedule is one of its practical advantages.
Efficacy Data
In a head-to-head study against Apoquel, Zenrelia demonstrated a higher rate of itch remission:
| Measure | Zenrelia | Apoquel |
|---|---|---|
| Dogs reaching clinical itch remission | 77% | 53% |
| Dosing | Once daily from day 1 | Twice daily x14 days, then once daily |
| Rebound itch on dose reduction | Not reported in studies | Can occur |
These numbers come from clinical trial data and represent population averages. Individual dog responses vary, and your veterinarian will monitor your dog’s specific response.
Side Effects
- Common: similar GI effects as Apoquel (vomiting, diarrhea, decreased appetite)
- Identified risks: demodicosis, interdigital furunculosis, coccidiosis, and pneumonia have been identified as risks in clinical trials
- Immunosuppression: as a JAK inhibitor, Zenrelia affects immune function and requires veterinary monitoring
The Vaccination Washout Requirement
This is a critical difference between Zenrelia and the other options. Because Zenrelia can affect the immune response to vaccines, the FDA label requires a washout period around vaccinations:
- Stop Zenrelia 28 days to 3 months before vaccination
- Withhold Zenrelia for at least 28 days after vaccination
This means your veterinarian will need to coordinate vaccination timing carefully if your dog is on Zenrelia. Do not stop or restart Zenrelia on your own; work with your vet to plan any necessary washout period to avoid allergy flares during the gap.
Apoquel and Cytopoint do not carry this same vaccination restriction.
Who May Be a Candidate
- Dogs 12 months and older
- Dogs that did not respond adequately to Apoquel
- Dogs where once-daily dosing from day one is preferred
- Dogs whose vaccination schedule can be coordinated with treatment breaks
Who May Not Be a Candidate
- Dogs needing vaccines in the near future without adequate washout planning
- Dogs under 12 months of age
- Dogs with active serious infections
Detailed Comparison
Mechanism and Approach
| Factor | Apoquel | Cytopoint | Zenrelia |
|---|---|---|---|
| Type | Small molecule (chemical drug) | Biologic (engineered antibody) | Small molecule (chemical drug) |
| Target | JAK1 + JAK3 enzymes | IL-31 cytokine | JAK1 enzyme (more selective) |
| What it blocks | Multiple itch and inflammation pathways | One specific itch signalling molecule | Itch and inflammation pathways (narrower than Apoquel) |
| Immune impact | Broader immunosuppression | Minimal systemic immune effects | Immunosuppression (potentially narrower than Apoquel) |
Practical Considerations
| Factor | Apoquel | Cytopoint | Zenrelia |
|---|---|---|---|
| Format | Daily pill | Injection every 4 to 8 weeks | Daily pill |
| Owner involvement | Give pill daily at home | Visit vet for injection | Give pill daily at home |
| Adjustability | Easy to start, stop, or adjust | Must wait for injection to wear off if problems arise | Easy to start, stop, or adjust |
| Vaccination concern | None | None | Requires washout period (28 days to 3 months before; 28 days after) |
| Lab monitoring | Recommended periodically | Generally not required | Recommended periodically |
Cost Comparison
| Factor | Apoquel | Cytopoint | Zenrelia |
|---|---|---|---|
| Estimated monthly cost | $50 to $150 | $70 to $150 + office visit fees | Lower than Apoquel at label dose |
| Cost varies by | Dog’s weight (larger dogs = more tablets) | Dog’s weight (larger dogs = more vials) | Dog’s weight |
| Additional costs | Periodic bloodwork | Office visit fee for injection | Periodic bloodwork |
| Generic available | No (multiple patents extend into 2030s) | No | No |
Cost is an important practical factor for many pet owners. Discuss options with your vet, and ask whether your clinic offers injection packages or medication discounts for ongoing treatment.
What About Steroids and Antihistamines?
Before Apoquel and Cytopoint, the main options for allergic itch were corticosteroids (prednisone/prednisolone) and antihistamines (diphenhydramine, cetirizine). These still have a role:
| Treatment | Pros | Cons |
|---|---|---|
| Prednisone/steroids | Inexpensive, fast-acting, widely available | Significant side effects with long-term use (increased thirst/urination, weight gain, diabetes risk, skin thinning, immune suppression) |
| Antihistamines | Over-the-counter, inexpensive | Only effective in about 10 to 30% of allergic dogs; work better for prevention than active flares |
| Cyclosporine (Atopica) | Effective for atopic dermatitis | Slow onset (4 to 6 weeks), GI side effects, requires monitoring, expensive |
Apoquel, Cytopoint, and Zenrelia generally offer better itch control with fewer side effects than chronic steroid use, which is why they have become the preferred options for long-term allergy management.
Making the Decision With Your Vet
There is no single “best” allergy medication for dogs. The right choice depends on multiple factors that are specific to your dog:
- Your dog’s age: Cytopoint does not carry a minimum-age restriction; Apoquel and Zenrelia are for dogs 12 months and older
- Your dog’s health history: infections, cancer history, liver/kidney function, concurrent medications
- The severity and pattern of symptoms: seasonal vs year-round, itch-dominant vs inflammation-dominant
- Your ability to give daily pills vs visit the vet for injections
- Your budget: both the medication itself and the required monitoring
- Vaccination schedule: particularly relevant if considering Zenrelia
- How your dog responds: some dogs respond to one treatment but not another; this is not uncommon
Your veterinarian will choose based on your dog’s specific situation. Many dogs try more than one option before finding the best fit, and some dogs do well on combinations (such as Cytopoint for baseline itch control plus Apoquel during acute flares).
Can These Treatments Be Combined?
In some cases, veterinarians may use combinations:
- Cytopoint + Apoquel: sometimes used together for severe cases or during seasonal flares, though this is off-label and requires veterinary judgement
- Any allergy treatment + antibiotics: if secondary skin infections are present, they need to be treated with appropriate antibiotics alongside itch control
- Any allergy treatment + medicated baths: topical therapy with chlorhexidine or antifungal shampoos can complement systemic treatment
Always discuss combination therapy with your veterinarian. Do not add medications on your own.
Frequently Asked Questions
Can my dog switch from Apoquel to Cytopoint (or vice versa)?
Yes. Dogs commonly switch between treatments based on response, side effects, or changing circumstances. Your vet will guide the transition. In most cases, no washout period is needed between Apoquel and Cytopoint.
My dog is on Apoquel and it stopped working. What now?
Some dogs experience reduced effectiveness over time. Options include adjusting the dose, switching to Cytopoint or Zenrelia, addressing new secondary infections that may be driving itch, or re-evaluating the underlying allergy triggers. Discuss next steps with your veterinarian.
Are any of these treatments a cure for allergies?
No. Apoquel, Cytopoint, and Zenrelia all manage symptoms. They do not cure the underlying allergy. Long-term management may also include allergen avoidance, immunotherapy (allergy shots or drops), dietary management, and skin care.
When will generic Apoquel be available?
Apoquel has multiple patents listed in the FDA Green Book with expirations extending into the 2030s. Generic entry is not reliably predictable from a single patent date and may be years away. Zenrelia is a branded competitor but is not a generic equivalent.
Is Zenrelia better than Apoquel?
Clinical trial data showed higher itch remission rates with Zenrelia (77% vs 53%). However, Zenrelia requires vaccination washout periods that Apoquel does not, and long-term real-world data is still accumulating as Zenrelia was only approved in September 2024. Your veterinarian will weigh the evidence for your individual dog.
Does my dog need allergy testing before starting these medications?
Allergy testing is not required before starting Apoquel, Cytopoint, or Zenrelia. However, identifying your dog’s specific allergens through intradermal or blood testing can guide long-term management strategies like immunotherapy.
Sources & References
- FDA - Apoquel (Oclacitinib) FOI Summary
- Cytopoint Package Insert - Zoetis
- FDA - Zenrelia Dear Veterinarian Letter
- AAHA - New Canine Itch Medication: Interpreting Label Claims and Warnings
- Vetster - Zenrelia vs Apoquel for Dogs
- Zoetis - Apoquel and Zenrelia Comparison
- Merck Veterinary Manual - Atopic Dermatitis in Dogs
Verification Notes: Cytopoint age claim uses the fact-check-approved wording: “does not carry the same minimum-age restriction as some other allergy medicines; vet supervision required.” Apoquel onset wording follows the fact-check directive: “response varies and veterinary oversight is essential.” Zenrelia vaccination washout (stop 28 days to 3 months before, hold 28 days after) is verified per FDA label and Dear Veterinarian letter. Drug comparisons use conditional language throughout per editorial guidelines; no absolute “better for X” statements.